Concurrent with these findings, analysis of public clinical data recorded in the TCGA and GEO databases demonstrated that EGFR-mutant lung-cancer patients whose tumors expressed higher JWA expression were associated with better overall survival (Figure 6R). Here, EGFR is linked to lung carcinoma.